tiprankstipranks
Advertisement
Advertisement

China Reinsurance Nominates Central Huijin Executive He Xingda to Board

Story Highlights
  • China Reinsurance has nominated He Xingda as a non-executive director for its fifth board session.
  • The nomination adds seasoned state-backed banking and insurance expertise, reinforcing China Reinsurance’s governance ties.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
China Reinsurance Nominates Central Huijin Executive He Xingda to Board

Meet Samuel – Your Personal Investing Prophet

China Reinsurance (Group) Corp. Class H ( (HK:1508) ) has shared an announcement.

China Reinsurance (Group) Corporation has nominated Central Huijin Investment Ltd. executive He Xingda as a non-executive director candidate for its fifth board session, pending approval at a shareholders’ general meeting and regulatory clearance from the National Financial Regulatory Administration. The move brings extensive banking and asset management experience to the board, as He has held senior roles at Central Huijin and New China Life Insurance affiliates, will receive no director’s remuneration under his service contract, and is expected to strengthen the group’s governance and ties with key state-backed financial institutions.

The most recent analyst rating on (HK:1508) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.

More about China Reinsurance (Group) Corp. Class H

China Reinsurance (Group) Corporation is a leading reinsurance group incorporated in the People’s Republic of China and listed in Hong Kong under stock code 1508. The company operates in the insurance and reinsurance sector, providing risk transfer and related financial solutions to insurers and other clients in domestic and international markets.

YTD Price Performance: -5.95%

Average Trading Volume: 20,685,572

Technical Sentiment Signal: Buy

Current Market Cap: HK$67.12B

For an in-depth examination of 1508 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1